Abstract
Abstract
Background
People with opioid use disorder (OUD) face barriers to entering and remaining in life-saving treatment (e.g., stigma, detrimental interactions with health care, and privacy concerns). Telehealth and related technology can reduce barriers to entering and staying in care. Patient feedback is critical to the development of these newer treatment approaches to ensure they are usable and do not inadvertently recreate treatment barriers.
Purpose
Evaluate the perceived usability of existing and planned features of a mobile application (app) that facilitates delivery of OUD treatment via telehealth.
Methods
People with current or prior experience with OUD treatment were eligible for the study. Participants (n = 31; 55% women) provided feedback on an interactive prototype demonstration via individual qualitative interviews and completed a quantitative survey on the app’s perceived usability. Descriptive statistics summarized the usability survey. We analyzed qualitative interview transcripts to elicit common themes.
Results
Participants were primarily white (77%) with a mean age of 42.2 years (range 22–69). Participants rated the six major features of the current app as helpful (median response 5 out of 5) and appreciated the flexibility of conducting a visit from a place of their choosing. Participants regarded the five proposed components of the app, such as daily affirmations and medication treatment-related reminders (e.g., pick up medication at pharmacy, medication schedule), as useful features with medians 5 out of 5, and reported they would recommend the app to others for OUD care. Participant qualitative interviews provided additional information on perceived usability of existing and proposed app features.
Conclusion
Our study suggests that an appealing, easy-to-use app—with tools and features that effectively support care—could circumvent existing barriers and foster sustained recovery.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. 2020 National Survey of Drug Use and Health (NSDUH) releases | CBHSQ data. https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and-health-nsduh-releases. Accessed 9 May 2022.
2. Hoffman KA, Baker R, Kunkel LE, Waddell EN, Lum PJ, McCarty D, et al. Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial. BMC Health Serv Res. 2019;19:862.
3. Patel K, Bunachita S, Agarwal AA, Lyon A, Patel UK. Opioid use disorder: treatments and barriers. Cureus. 2021;13: e13173.
4. Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. MMWR Surveill Summ. 2017;66:1–12.
5. Grimm C. Geographic disparities affect access to buprenorphine services for opioid use disorder. US Department of Health and Human Services—Office of the Inspector General; 2020. https://oig.hhs.gov/oei/reports/oei-12-17-00240.pdf.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献